Novel antisense drug shows promise in slowing fatty liver disease LiveStream Wednesday, June 17, 2020 Science Leave a Reply A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form. source https://www.sciencedaily.com/releases/2020/06/200616135737.htm
0 comments: